Plasmid-mediated antibiotic resistance illustrates extraordinary plasticity of bacterial accessory genome and its clinical impact. Resistance R-plasmids and conjugative plasmids frequently carry multiple gene cassettes encoding distinct resistance mechanisms: beta-lactamases including TEM, SHV, CTX-M that hydrolyze beta-lactam rings, aminoglycoside-modifying enzymes such as acetyltransferases AAC, phosphotransferases APH, nucleotidyltransferases ANT that acetylate, phosphorylate or adenylate aminoglycosides, macrolide efflux pumps encoded by mef genes and target modification via erm methylases that dimethylate A2058 of 23S rRNA, tet efflux pumps tetA/K and ribosomal protection, chloramphenicol acetyltransferases cat, and sulfonamide-resistant dihydropteroate synthases sul1 and sul2 with low drug affinity. Because plasmids are replicons not limited to one antibiotic class, they accumulate multidrug resistance regions via transposons like Tn3, integrons with integrase intI1 and insertion sequences. Mobilization through conjugation requiring tra operon and sex pilus, transformation and phage transduction spreads them rapidly among Gram-positive and Gram-negative pathogens even across species, explaining why resistance to beta-lactams, macrolides and aminoglycosides can be simultaneously plasmid-associated rather than restricted to single class, complicating empirical therapy and necessitating stewardship.
Ref:
Madigan et al., Brock Biology of Microorganisms, 16th ed., Chapter 9: Plasmid-Mediated Multidrug Resistance Mechanisms.